Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

Go/no-go decisions for the PI3K and ENPP1 programs are expected in the second half of 2025 following the completion of IND-enabling studies. Future clinical updates include early safety and PK data ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...

Apheris's ADMET Network will combine proprietary datasets in a privacy-preserving environment to accelerate AI drug discovery models.

VectorCertain's AIEOG Conformance Suite reveals that the Prevention Gap has a physical address: over 1.2 billion processors which process trillions of dollars daily with no on-device AI defense ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the ...